199 related articles for article (PubMed ID: 15570193)
1. Assessment of thiopurine methyltransferase and metabolite formation during thiopurine therapy: results from a large Swedish patient population.
Hindorf U; Peterson C; Almer S
Ther Drug Monit; 2004 Dec; 26(6):673-8. PubMed ID: 15570193
[TBL] [Abstract][Full Text] [Related]
2. Possibilities for therapeutic drug monitoring of azathioprine: 6-thioguanine nucleotide concentrations and thiopurine methyltransferase activity in red blood cells.
Bergan S; Rugstad HE; Klemetsdal B; Giverhaug T; Bentdal O; Sødal G; Hartmann A; Aarbakke J; Stokke O
Ther Drug Monit; 1997 Jun; 19(3):318-26. PubMed ID: 9200774
[TBL] [Abstract][Full Text] [Related]
3. Characterisation and utility of thiopurine methyltransferase and thiopurine metabolite measurements in autoimmune hepatitis.
Hindorf U; Jahed K; Bergquist A; Verbaan H; Prytz H; Wallerstedt S; Werner M; Olsson R; Björnsson E; Peterson C; Almer SH
J Hepatol; 2010 Jan; 52(1):106-11. PubMed ID: 19906459
[TBL] [Abstract][Full Text] [Related]
4. IMPDH activity in thiopurine-treated patients with inflammatory bowel disease - relation to TPMT activity and metabolite concentrations.
Haglund S; Taipalensuu J; Peterson C; Almer S
Br J Clin Pharmacol; 2008 Jan; 65(1):69-77. PubMed ID: 17662091
[TBL] [Abstract][Full Text] [Related]
5. Thiopurine pharmacogenetics in leukemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations.
Lennard L; Van Loon JA; Lilleyman JS; Weinshilboum RM
Clin Pharmacol Ther; 1987 Jan; 41(1):18-25. PubMed ID: 3467886
[TBL] [Abstract][Full Text] [Related]
6. High 6-thioguanine nucleotide levels and low thiopurine methyltransferase activity in patients with lupus erythematosus treated with azathioprine.
Decaux G; Horsmans Y; Houssiau F; Desager JP
Am J Ther; 2001; 8(3):147-50. PubMed ID: 11344381
[TBL] [Abstract][Full Text] [Related]
7. ITPA Activity in Adults and Children Treated With or Without Azathioprine: Relationship Between TPMT Activity, Thiopurine Metabolites, and Co-medications.
Citterio-Quentin A; Moulsma M; Gustin MP; Boulieu R
Ther Drug Monit; 2017 Oct; 39(5):483-491. PubMed ID: 28650902
[TBL] [Abstract][Full Text] [Related]
8. Red Blood cell IMPDH activity in adults and children with or without azathioprine: Relationship between thiopurine metabolites, ITPA and TPMT activities.
Citterio-Quentin A; El Mahmoudi A; Perret T; Conway A; Ryan A; Beringer A; Lachaux A; Boulieu R
Basic Clin Pharmacol Toxicol; 2019 May; 124(5):600-606. PubMed ID: 30451390
[TBL] [Abstract][Full Text] [Related]
9. Thiopurine methyltransferase genotype-phenotype discordance and thiopurine active metabolite formation in childhood acute lymphoblastic leukaemia.
Lennard L; Cartwright CS; Wade R; Richards SM; Vora A
Br J Clin Pharmacol; 2013 Jul; 76(1):125-36. PubMed ID: 23252716
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological monitoring of azathioprine therapy.
Reuther LO; Sonne J; Larsen NE; Larsen B; Christensen S; Rasmussen SN; Tofteng F; Haaber A; Johansen N; Kjeldsen J; Schmiegelow K
Scand J Gastroenterol; 2003 Sep; 38(9):972-7. PubMed ID: 14531535
[TBL] [Abstract][Full Text] [Related]
11. Differences between children and adults in thiopurine methyltransferase activity and metabolite formation during thiopurine therapy: possible role of concomitant methotrexate.
Pettersson B; Almer S; Albertioni F; Söderhäll S; Peterson C
Ther Drug Monit; 2002 Jun; 24(3):351-8. PubMed ID: 12021625
[TBL] [Abstract][Full Text] [Related]
12. Comparison of three methods for measuring thiopurine methyltransferase activity in red blood cells and human leukemia cells.
Karim H; Appell ML; Fotoohi A
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 939():80-5. PubMed ID: 24113235
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of azathioprine metabolites for the maintenance of remission in autoimmune hepatitis.
Dhaliwal HK; Anderson R; Thornhill EL; Schneider S; McFarlane E; Gleeson D; Lennard L
Hepatology; 2012 Oct; 56(4):1401-8. PubMed ID: 22488741
[TBL] [Abstract][Full Text] [Related]
14. Thiopurine dose in intermediate and normal metabolizers of thiopurine methyltransferase may differ three-fold.
Gardiner SJ; Gearry RB; Begg EJ; Zhang M; Barclay ML
Clin Gastroenterol Hepatol; 2008 Jun; 6(6):654-60; quiz 604. PubMed ID: 18467186
[TBL] [Abstract][Full Text] [Related]
15. Thiopurine methyltransferase and 6-thioguanine nucleotide measurement: early experience of use in clinical practice.
Gearry RB; Barclay ML; Roberts RL; Harraway J; Zhang M; Pike LS; George PM; Florkowski CM
Intern Med J; 2005 Oct; 35(10):580-5. PubMed ID: 16207256
[TBL] [Abstract][Full Text] [Related]
16. Prospective Evaluation of Pharmacogenomics and Metabolite Measurements upon Azathioprine Therapy in Inflammatory Bowel Disease: An Observational Study.
Fangbin Z; Xiang G; Liang D; Hui L; Xueding W; Baili C; Huichang B; Yinglian X; Peng C; Lizi Z; Yanjun C; Feng X; Minhu C; Min H; Pinjin H
Medicine (Baltimore); 2016 Apr; 95(15):e3326. PubMed ID: 27082580
[TBL] [Abstract][Full Text] [Related]
17. [Optimising azathioprine treatment: determination of thiopurine methyltransferase activity and thiopurine metabolites].
Alvarez Beltran M; Infante Pina D; Tormo Carnicé R; Segarra Cantón O; Redecillas Ferreiro S
An Pediatr (Barc); 2009 Feb; 70(2):126-31. PubMed ID: 19217567
[TBL] [Abstract][Full Text] [Related]
18. Should 6-thioguanine nucleotides be monitored in heart transplant recipients given azathioprine?
Schütz E; Gummert J; Mohr FW; Armstrong VW; Oellerich M
Ther Drug Monit; 1996 Jun; 18(3):228-33. PubMed ID: 8738760
[TBL] [Abstract][Full Text] [Related]
19. Interindividual variability in TPMT enzyme activity: 10 years of experience with thiopurine pharmacogenetics and therapeutic drug monitoring.
Chouchana L; Narjoz C; Roche D; Golmard JL; Pineau B; Chatellier G; Beaune P; Loriot MA
Pharmacogenomics; 2014 Apr; 15(6):745-57. PubMed ID: 24897283
[TBL] [Abstract][Full Text] [Related]
20. Thiopurine methyltransferase activity and its relationship to the occurrence of rejection episodes in paediatric renal transplant recipients treated with azathioprine.
Dervieux T; Médard Y; Baudouin V; Maisin A; Zhang D; Broly F; Loirat C; Jacqz-Aigrain E
Br J Clin Pharmacol; 1999 Dec; 48(6):793-800. PubMed ID: 10594482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
